Following a full submission
AWMSG advice |
|||
| Status: Recommended | |||
Colecalciferol (Fultium-D3®) is recommended as an option for use within NHS Wales for the prevention and treatment of vitamin D deficiency and as an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency. Fultium-D3® is indicated in adults, the elderly and adolescents. |
|||
|
|||
Medicine details |
|||
| Medicine name | colecalciferol (Fultium-D3®) | ||
| Formulation | 800 units capsule | ||
| Reference number | 1499 | ||
| Indication | Prevention and treatment of vitamin D deficiency and as an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency. Fultium-D3 is indicated in adults, the elderly and adolescents |
||
| Company | Internis Pharmaceuticals Ltd | ||
| BNF chapter | Nutrition & blood | ||
| Submission type | Full | ||
| Status | Recommended | ||
| Advice number | 3612 | ||
| NMG meeting date | 05/09/2012 | ||
| AWMSG meeting date | 17/10/2012 | ||
| Ratification by Welsh Government | 09/11/2012 | ||
| Date of issue | 13/12/2012 | ||
| Date of last review | 30/09/2016 | ||